Blueprint Medicines Corp at Morgan Stanley Global Healthcare Conference (Virtual) Transcript
Hello, and good afternoon. Welcome, again, to the 19th Annual Morgan Stanley Healthcare Conference. Before I get going, let me just go through the requisite disclosures. For important disclosures, please see the Morgan Stanley research disclosure website at www.morganstanley.com/researchdisclosures. If you have any questions, please reach out to your Morgan Stanley sales representative.
And with that, let me introduce myself. I'm Dave Lebowitz, one of the biotechnology analysts here. I have with me in the next session from Blueprint Medicines COO, Kate Haviland; and President of Research and Development, Fouad Namouni.
Questions & Answers
I guess if you could start maybe to give a top line description of the company, what has happened? There's certainly been an evolution in the last couple of years, a lot of changes and where you're
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
